Manipulation of dendritic cell function by viruses

Current Opinion in Microbiology

Volumn 13, Issue 4, 2010, Pages 524-529

  Cunningham, Anthony L ^a   Donaghy, Heather ^a   Harman, Andrew N ^a   Kim, Min ^a   Turville, Stuart G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 8; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SYNAPTOTAGMIN I; TIFUVIRTIDE; TOLL LIKE RECEPTOR; VIRUS RNA;

ADAPTIVE IMMUNITY; ADENOVIRUS; ANTIGEN PRESENTATION; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL FUNCTION; CELL MIGRATION; COMPETITIVE INHIBITION; CYTOKINE PRODUCTION; DENDRITIC CELL; EBOLA VIRUS; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN METAPNEUMOVIRUS; IMMUNOCOMPETENT CELL; INFLUENZA VIRUS; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MEASLES VIRUS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PARAMYXOVIRUS; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVIEW; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION;

ANIMALS; BIOLOGICAL TRANSPORT; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUS INTERNALIZATION; VIRUS REPLICATION; VIRUSES;

HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77955415540     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2010.06.002     Document Type: Review

References (51)

1. Harman A.N., Wilkinson J., Bye C.R., Bosnjak L., Stern J.L., Nicholle M., Lai J., Cunningham A.L. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 2006, 177:7103-7113.
2. Harman A.N., Kraus M., Bye C.R., Byth K., Turville S.G., Tang O., Mercier S.K., Nasr N., Stern J.L., Slobedman B., et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 2009, 114:85-94.
3. Yu H.J., Reuter M.A., McDonald D. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog 2008, 4:e1000134.
4. Cavrois M., Neidleman J., Kreisberg J.F., Greene W.C. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 2007, 3:pe4.
5. Izquierdo-Useros N., Naranjo-Gomez M., Archer J., Hatch S.C., Erkizia I., Blanco J., Borràs F.E., Puertas M.C., Connor J.H., Fernández-Figueras M.T., et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 2009, 113:2732-2741.
6. Gringhuis S.I., van der Vlist M., van den Berg L.M., den Dunnen J., Litjens M., Geijtenbeek T.B. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010, 11:419-426.
7. Garcia E., Nikolic D.S., Piguet V. HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3. Traffic 2008, 9:200-214.
8. Turville S.G., Aravantinou M., Stossel H., Romani N., Robbiani M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat Methods 2008, 5:75-85.
9. Sandgren K.J., Wilkinson J., Miranda-Saksena M., McInerney G., Blyth Wilson K., Robinson P., Cunningham A.L. A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Med 2010, 6:e1000866.
10. Bonjardim C.A., Ferreira P.C., Kroon E.G. Interferons: signaling, antiviral and viral evasion. Immunol Lett 2009, 122:1-11.
11. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
12. Goutagny N., Jiang Z., Tian J., Parroche P., Schickli J., Monks B.G., Ulbrandt N., Ji H., Kiener P.A., Coyle A.J., Fitzgerald K.A. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J Immunol 2010, 184:1168-1179.
13. Pfaller C.K., Conzelmann K.K. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 2008, 82:12365-12373.
14. Abt M., Gassert E., Schneider-Schaulies S. Measles virus modulates chemokine release and chemotactic responses of dendritic cells. J Gen Virol 2009, 90(Part 4):909-914.
15. Buettner N., Vogt C., Martinez-Sobrido L., Weber F., Waibler Z., Kochs G. Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol 2010, 91(Part 1):220-227.
16. Yu S, Chen J, Wu M, Chen H, Yuan Z: The hepatitis B virus polymerase inhibits RIG-I-and toll like receptor 3 mediated interferon (beta) induction in human hepatocytes through interference with interferon regulatory factor3 activation and dampening of the interaction between Tbk/IKK(varepsilon) and Ddx3. J Gen Virol 2010, in press.
17. Rodriguez-Madoz J.R., Bernal-Rubio D., Kaminski D., Boyd K., Fernandez-Sesma A. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 2010, 84:4845-4850.
18. Myskiw C., Arsenio J., van Bruggen R., Deschambault Y., Cao J. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol 2009, 83:6757-6768.
19. Shingai M., Azuma M., Ebihara T., Sasai M., Funami K., Ayata M., Ogura H., Tsutsumi H., Matsumoto M., Seya T. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Int Immunol 2008, 20:1169-1180.
20. Cotter C.R., Nguyen M.L., Yount J.S., Lopez C.B., Blaho J.A., Moran T.M. The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells. PLoS One 2010, 5:e8684.
21. Jin H., Yan Z., Prabhakar B.S., Feng Z., Ma Y., Verpooten D., Ganesh B., He B. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide. J Gen Virol 2010, 91(Part 2):352-361.
22. Jin H., Ma Y., Prabhakar B.S., Feng Z., Valyi-Nagy T., Yan Z., Verpooten D., Zhang C., Cao Y., He B. The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection. J Virol 2009, 83:4984-4994.
23. Bosnjak L., Miranda-Saksena M., Koelle D.M., Boadle R.A., Jones C.A., Cunningham A.L. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005, 174:2220-2227.
24. Liu l, Chavan R., Feinberg M.B. Dendritic cells are preferentially targetted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cells responses in vivo. BMC Immunol 2008, 15:9-15.
25. Brilot F., Strowig T., Munz C. NK cells interactions with dendritic cells shape innate and adaptive immunity. Front Biosci 2008, 13:6443-6454.
26. Saidi H., Melki M.T., Gougeon M.L. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. PLoS One 2008, 3:e3601.
27. Draghi M., Pashine A., Sanjanwala B., Gendzekhadze K., Cantoni C., Cosman D., Moretta A., Valiante N.M., Parham P. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 2007, 178:2688-2698.
28. Kassim S.H., Rajasagi N.K., Ritz B.W., Pruett S.B., Gardner E.M., Chervenak R., Jennings S.R. Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1. J Virol 2009, 83:3175-3186.
29. Cederarv M., Soderberg-Naucler C., Odeberg J. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Immunobiology 2009, 214:331-341.
30. Conry S.J., Milkovich K.A., Yonkers N.L., Rodriguez B., Bernstein H.B., Asaad R., Heinzel F.P., Tary-Lehmann M., Lederman M.M., Anthony D.D. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 2009, 83:11175-11187.
31. Fontenot D., He H., Hanabuchi S., Nehete P.N., Zhang M., Chang M., Nehete B., Wang Y.H., Wang Y.H., Ma Z.M., et al. TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc Natl Acad Sci U S A 2009, 106:16776-16781.
32. Ceballos A., Remes Lenicov F., Sabatté J., Rodríguez Rodrígues C., Cabrini M., Jancic C., Raiden S., Donaldson M., Agustín Pasqualini R., Marin-Briggiler C., et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med 2009, 206:2717-2733.
33. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005, 23:275-306.
34. Donaghy H., Bosnjak L., Harman A.N., Marsden V., Tyring S.K., Meng T.C., Cunningham A.L. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol 2009, 83:1952-1961.
35. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., Remington M., Magaret A., Koelle D.M., Wald A., Corey L. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009, 15:886-892.
36. Huch J.H., Cunningham A.L., Arvin A.M., Nasr N., Santegoets S.J., Slobedman E., Slobedman B., Abendroth A. Impact of varicella zoster virus on dendritic cell subsets in human skin during natural infection. J Virol 2010, 84:4060-4072.
37. Li Q., Estes J.D., Schlievert P.M., Duan L., Brosnahan A.J., Southern P.J., Reilly C.S., Peterson M.L., Schultz-Darken N., Brunner K.G., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
38. Mandl J.N., Barry A.P., Vanderford T.H., Kozyr N., Chavan R., Klucking S., Barrat F.J., Coffman R.L., Staprans S.I., Feinberg M.B. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008, 14:1077-1087.
39. Campillo-Gimenez L., Laforge M., Fay M., Brussel A., Cumont M.C., Monceaux V., Diop O., Lévy Y., Hurtrel B., Zaunders J., et al. Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 2010, 84:1838-1846.
40. Stoddart C.A, Keir M.E., McCune J.M. IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo. PLoS Pathog 2010, 6:e1000766.
41. Miller C.J., Li Q., Abel K., Kim E.Y., Ma Z.M., Wietgrefe S., La Franco-Scheuch L., Compton L., Duan L., Shore M.D., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005, 79:9217-9227.
42. Takahashi K., Asabe S., Wieland S., Garaigorta U., Gastaminza P., Isogawa M., Chisari F.V. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 2010, 107:7431-7436.
43. Amjad M., Abdel-Haq N., Faisal M., Kamal M., Moudgal V. Decreased interferon-alpha production and impaired regulatory function of plasmacytoid dendritic cells induced by the hepatitis C virus NS 5 protein. Microbiol Immunol 2008, 52:499-507.
44. Chang W.L., Barry P.A., Szubin R., Wang D., Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009, 390:330-337.
45. Schneider K., Meyer-Koenig U., Hufert F.T. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS One 2008, 3:e3482.
46. Kumagai Y., Kumar H., Koyama S., Kawai T., Takeuchi O., Akira S. Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J Immunol 2009, 182:3960-3964.
47. Villadangos J.A., Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008, 29:352-361.
48. Manches O., Munn D., Fallahi A., Lifson J., Chaperot L., Plumas J., Bhardwaj N. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest 2008, 118:3431-3439.
49. Malleret B., Manéglier B., Karlsson I., Lebon P., Nascimbeni M., Perié L., Brochard P., Delache B., Calvo J., Andrieu T., et al. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 2008, 112:4598-4608.
50. Langlois R.A., Legge K.L. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J Immunol 2010, 184:4440-4446.
51. Lui G., Manches O., Angel J., Molens J.P., Chaperot L., Plumas J. Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PLoS One 2009, 4:e7111.